QHSLab enters alliance with Medical License Factory
June 24, 2022 -- QHSLab is entering into a strategic alliance with Medical License Factory for its AllergiEnd allergy diagnostic test and allergen immunotherapy products, as well as clinical decision support digital health services. Read More
Biocartis, AstraZeneca to develop CDx for EGFR TKI treatment
June 22, 2022 -- Biocartis has signed a deal to codevelop a companion diagnostic test (CDx) with AstraZeneca for the pharma firm’s epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) treatment Tagrisso (osimertinib). Read More
Blood grouping, typing market estimated at $945 million
June 17, 2022 -- In 2021, the world market for blood grouping and blood typing rebounded from a 3.2% decline in 2020 due to COVID-19 impacts, reaching an estimated $945 million in revenues, according to an upcoming issue of the In Vitro Diagnostics Business Outlook. Read More
Roche launches HPV self-sampling solution
June 16, 2022 -- Roche said on Thursday that it has launched a human papillomavirus (HPV) self-sampling solution that enables a patient to privately collect her sample for HPV screening in countries accepting the CE Mark. Read More
Chembio launching direct-to-consumer SARS-CoV-2 self-test
June 16, 2022 -- Chembio Diagnostics has launched a direct-to-consumer (DTC) commercial channel in the U.S. for the InBios International SCoV-2 Ag Detect Self-Test. Read More
GBS to acquire drug screening firm Intelligent Fingerprinting
June 16, 2022 -- GBS has inked a deal to acquire Intelligent Fingerprinting, a developer of point-of-care diagnostic screening technology for opioids and drugs of abuse. Read More
FDA issues EUA for Labcorp NGS test to detect SARS-CoV-2 strains
June 13, 2022 -- The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for the Laboratory Corporation of America (Labcorp) VirSeq SARS-CoV-2 NGS Test on the PacBio Sequel II sequencing system. Read More
Alzheimer’s test developer Diadem joins DPUK
June 13, 2022 -- Diadem, the developer of a blood test for the early prediction of progression to Alzheimer’s disease, on Monday announced it has joined Dementias Platform UK (DPUK) as a corporate partner. Read More
Study: less than half of pregnant people screened for HCV
June 13, 2022 -- A joint study conducted by Quest Diagnostics and the U.S. Centers for Disease Control and Prevention (CDC) has found that while the rate of hepatitis C (HCV) antibody screening increased 145% in pregnant people during the decade-long study period ending in June 2021, less than half of all pregnant people were screened in early 2021. Read More
DxTerity Diagnostics launches gene expression test for lupus
June 10, 2022 -- DxTerity Diagnostics on Thursday announced the launch of its gene expression IFN-1 Test for patients with lupus. Read More